Safety of teriflunomide in Chinese adult patients with relapsing multiple sclerosis: A phase IV, 24-week multicenter study

Safety of teriflunomide in Chinese adult patients with relapsing multiple sclerosis: A phase IV, 24-week multicenter study

Abstract. Background:. Disease-modifying therapies have been approved for the treatment of relapsing multiple sclerosis (RMS). The present study aims to examine the safety of teriflunomide in Chinese patients with RMS. Methods:. This non-randomized, multi-center, 24-week, prospective study enrolled...

Full description

Saved in:
Bibliographic Details
Main Authors: Chao Quan, Hongyu Zhou, Huan Yang, Zheng Jiao, Meini Zhang, Baorong Zhang, Guojun Tan, Bitao Bu, Tao Jin, Chunyang Li, Qun Xue, Huiqing Dong, Fudong Shi, Xinyue Qin, Xinghu Zhang, Feng Gao, Hua Zhang, Jiawei Wang, Xueqiang Hu, Yueting Chen, Jue Liu, Wei Qiu, Ting Gao, Xiuyuan Hao
Format: Article
Language:English
Published: Wolters Kluwer 2025-02-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000002990
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://journals.lww.com/10.1097/CM9.0000000000002990

Similar Items